These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2781539)

  • 1. Effects of glycyrrhizin (SNMC: stronger Neo-Minophagen C) in hemophilia patients with HIV infection.
    Mori K; Sakai H; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Seino Y; Ishida N; Uchida T; Kariyone S
    Tohoku J Exp Med; 1989 May; 158(1):25-35. PubMed ID: 2781539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection.
    Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Imaizumi M; Tada K; Aihara M; Sawada Y; Yokoyama M
    Tohoku J Exp Med; 1990 Oct; 162(2):183-93. PubMed ID: 2129071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan].
    Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y
    Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS.
    Hattori T; Ikematsu S; Koito A; Matsushita S; Maeda Y; Hada M; Fujimaki M; Takatsuki K
    Antiviral Res; 1989; 11(5-6):255-61. PubMed ID: 2572198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression.
    Watanbe H; Miyaji C; Makino M; Abo T
    Biotherapy; 1996; 9(4):209-20. PubMed ID: 9012540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection.
    Numazaki K; Umetsu M; Chiba S
    Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The frequency of patients with positive HIV-antibody in the various groups and the prognosis of these patients treated with SNMC].
    Endo Y; Mamiya S; Iwamoto K; Niitsu H; Itoh T; Miura A
    Rinsho Byori; 1990 Feb; 38(2):188-92. PubMed ID: 2329721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
    Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
    Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
    Kumada H
    Oncology; 2002; 62 Suppl 1():94-100. PubMed ID: 11868794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural course and trial of treatment for infantile liver dysfunction associated with cytomegalovirus infections.
    Numazaki K; Chiba S
    In Vivo; 1993; 7(6A):477-80. PubMed ID: 8193264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency in patients with hemophilia: an underlying deficiency and lack of correlation with factor replacement therapy or exposure to human immunodeficiency virus.
    Jin ZW; Cleveland RP; Kaufman DB
    J Allergy Clin Immunol; 1989 Jan; 83(1):165-70. PubMed ID: 2913135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice.
    Shibata S
    Yakugaku Zasshi; 2000 Oct; 120(10):849-62. PubMed ID: 11082698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification.
    Nakashima H; Matsui T; Yoshida O; Isowa Y; Kido Y; Motoki Y; Ito M; Shigeta S; Mori T; Yamamoto N
    Jpn J Cancer Res; 1987 Aug; 78(8):767-71. PubMed ID: 2443473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
    Miyake K; Tango T; Ota Y; Mitamura K; Yoshiba M; Kako M; Hayashi S; Ikeda Y; Hayashida N; Iwabuchi S; Sato Y; Tomi T; Funaki N; Hashimoto N; Umeda T; Miyazaki J; Tanaka K; Endo Y; Suzuki H
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1198-204. PubMed ID: 12453280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
    Lederman MM; Ratnoff OD; Schacter B; Shoger T
    J Lab Clin Med; 1985 Aug; 106(2):197-204. PubMed ID: 2410523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bronchial asthma due to Stronger Neo-Minophagen C].
    Nakatsumi Y; Abe T; Nomura G; Fujimura M; Matsuda T
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):644-6. PubMed ID: 9805919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
    Hidaka I; Hino K; Korenaga M; Gondo T; Nishina S; Ando M; Okuda M; Sakaida I
    Liver Int; 2007 Aug; 27(6):845-53. PubMed ID: 17617128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on serum neopterin concentration in hemophiliacs with anti-human immunodeficiency-virus type I antibody].
    Matsuda J
    Rinsho Byori; 1991 Jul; 39(7):743-7. PubMed ID: 1920867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
    N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravenous stronger neo-minophagen C and S-adenosyl-L-methionine in treatment of pregnant woman with chronic hepatitis B: a pilot study.
    Sun QF; Ding JG; Wang XF; Fu RQ; Yang JX; Hong L; Xu XJ; Wang JR; Wu JG; Xu DZ
    Med Sci Monit; 2010 Aug; 16(8):PR9-14. PubMed ID: 20671623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.